Grant: Discovery Grants Program - Individual
University of Guelph
$72,000.00
Host--pathogen interactions in Mycoplasma bovis pneumonia of cattle
EF 2024-25
Résumé
Mycoplasma bovis has emerged as a major cause of bacterial pneumonia in cattle. It is economically important to the Canadian beef, dairy and veal industries, is a welfare issue because of animal suffering from chronic disease, and prevention and control of respiratory disease is a major reason for antibiotic use in cattle. However, control methods are limited by a lack of understanding of how the disease develops. Death of recruited leukocytes is characteristic of M. bovis pneumonia and a reason that infected animals develop progressive disease despite antibiotic therapy and a robust immune response. Prior inflammation in the lung of healthy calves promotes this cell death process and leads to more severe clinical disease. Since M. bovis and other pathogens are both present in the natural disease, we hypothesize that prior inflammation triggered by these co-pathogens disrupts innate immune tolerance; specifically, tipping the balance from quiet elimination of bacteria toward heightened inflammation and cell death in the lung of infected calves.
Using our newly developed model, we first determine the molecular mechanisms by which M. bovis incites this form of cell death, to better understand this key aspect of how the disease develops. Secondly, we evaluate how prior inflammation and immune responses affect the interactions between M. bovis and host cells (macrophages and neutrophils), by determining how different prior inflammatory stimuli lead to different outcomes of inflammation and death of host cells upon subsequent infection with M. bovis. Third, we investigate how M. bovis isolates differ in their propensity to trigger inflammatory responses and death of macrophages.
Identifying how prior inflammation predisposes to harmful outcomes of M. bovis infection advances knowledge of innate immune tolerance in polymicrobial infections, and changes how we understand this important cattle disease in a way that will impact disease prevention. For example, these studies will guide further development of pathway-specific anti-inflammatory drugs, may lead to tests to differentiate more-virulent vs less-virulent M. bovis strains to better control disease in infected herds, or direct development of vaccines that target virulence-associated antigens or that skew the induced immune response toward innate immune tolerance and more favourable outcomes. Because M. bovis pneumonia, arthritis and otitis are so common in modern production systems, improved control methods will benefit Canada's beef, dairy and veal sectors, improve the animal welfare impacts of these chronic diseases, and provide alternatives to mass medication with antibiotics for disease prevention. Further, these studies address fundamental aspects of host-pathogen interaction including how infections and inflammatory stimuli dysregulate host responses, and thereby alter the response to other pathogens in polymicrobial infections.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2023-03307
Name nom
Caswell, Jeff
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Host--pathogen interactions in Mycoplasma bovis pneumonia of cattle
Keywords
veterinary medicine; beef cattle; respiratory diseases; pneumonia; mycoplasma bovis; innate immunity; inflammation; host-pathogen interaction; pulmonary alveolar macrophages; pathogenesis
Application summary
Mycoplasma bovis has emerged as a major cause of bacterial pneumonia in cattle. It is economically important to the Canadian beef, dairy and veal industries, is a welfare issue because of animal suffering from chronic disease, and prevention and control of respiratory disease is a major reason for antibiotic use in cattle. However, control methods are limited by a lack of understanding of how the disease develops. Death of recruited leukocytes is characteristic of M. bovis pneumonia and a reason that infected animals develop progressive disease despite antibiotic therapy and a robust immune response. Prior inflammation in the lung of healthy calves promotes this cell death process and leads to more severe clinical disease. Since M. bovis and other pathogens are both present in the natural disease, we hypothesize that prior inflammation triggered by these co-pathogens disrupts innate immune tolerance; specifically, tipping the balance from quiet elimination of bacteria toward heightened inflammation and cell death in the lung of infected calves.
Using our newly developed model, we first determine the molecular mechanisms by which M. bovis incites this form of cell death, to better understand this key aspect of how the disease develops. Secondly, we evaluate how prior inflammation and immune responses affect the interactions between M. bovis and host cells (macrophages and neutrophils), by determining how different prior inflammatory stimuli lead to different outcomes of inflammation and death of host cells upon subsequent infection with M. bovis. Third, we investigate how M. bovis isolates differ in their propensity to trigger inflammatory responses and death of macrophages.
Identifying how prior inflammation predisposes to harmful outcomes of M. bovis infection advances knowledge of innate immune tolerance in polymicrobial infections, and changes how we understand this important cattle disease in a way that will impact disease prevention. For example, these studies will guide further development of pathway-specific anti-inflammatory drugs, may lead to tests to differentiate more-virulent vs less-virulent M. bovis strains to better control disease in infected herds, or direct development of vaccines that target virulence-associated antigens or that skew the induced immune response toward innate immune tolerance and more favourable outcomes. Because M. bovis pneumonia, arthritis and otitis are so common in modern production systems, improved control methods will benefit Canada's beef, dairy and veal sectors, improve the animal welfare impacts of these chronic diseases, and provide alternatives to mass medication with antibiotics for disease prevention. Further, these studies address fundamental aspects of host-pathogen interaction including how infections and inflammatory stimuli dysregulate host responses, and thereby alter the response to other pathogens in polymicrobial infections.